189 research outputs found
The Intermediate Coupling Regime in the AdS/CFT Correspondence
The correspondence between the 't Hooft limit of N=4 super Yang-Mills theory
and tree-level IIB superstring theory on AdS(5)xS(5) in a Ramond-Ramond
background at values of lambda=g^2 N ranging from infinity to zero is examined
in the context of unitarity. A squaring relation for the imaginary part of the
holographic scattering of identical string fields in the two-particle channels
is found, and a mismatch between weak and strong 't Hooft coupling is pointed
out within the correspondence. Several interpretations and implications are
proposed.Comment: 10 pages, LaTeX, reference adde
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke
<p><b>Background and Purpose:</b> Several prospective studies have shown significant associations between plasma fibrinogen, viscosity, C-reactive protein (CRP), fibrin D-dimer, or tissue plasminogen activator (tPA) antigen and the risk of primary cardiovascular events. Little has been published on the associations of these variables with recurrent stroke. We studied such associations in a nested case-control study derived from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).</p>
<p><b>Methods:</b> Nested case-control study of ischemic (n=472) and hemorrhagic (n=83) strokes occurring during a randomized, placebo-controlled multicenter trial of perindopril-based therapy in 6105 patients with a history of stroke or transient ischemic attack. Controls were matched for age, treatment group, sex, region, and most recent qualifying event at entry to the parent trial.</p>
<p><b>Results:</b> Fibrinogen and CRP were associated with an increased risk of recurrent ischemic stroke after accounting for the matching variables and adjusting for systolic blood pressure, smoking, peripheral vascular disease, and statin and antiplatelet therapy. The odds ratio for the last compared with the first third of fibrinogen was 1.34 (95% CI, 1.01 to 1.78) and for CRP was 1.39 (95% CI, 1.05 to 1.85). After additional adjustment for each other, these 2 odds ratios stayed virtually unchanged. Plasma viscosity, tPA, and D-dimer showed no relationship with recurrent ischemic stroke, although tPA was significant for lacunar and large artery subtypes. Although each of these variables showed a negative relationship with recurrent hemorrhagic stroke, none of these relationships achieved statistical significance.</p>
<p><b>Conclusions:</b> Fibrinogen and CRP are risk predictors for ischemic but not hemorrhagic stroke, independent of potential confounders.</p>
Response to Nauenberg's "Critique of Quantum Enigma: Physics Encounters Consciousness"
Nauenberg's extended critique of Quantum Enigma rests on fundamental
misunderstandings.Comment: To be published in Foundations of Physic
Macrolide antibiotics for bronchiectasis
Background Bronchiectasis is a chronic respiratory disease characterised by abnormal and irreversible dilatation and distortion of the smaller airways. Bacterial colonisation of the damaged airways leads to chronic cough and sputum production, often with breathlessness and further structural damage to the airways. Long-term macrolide antibiotic therapy may suppress bacterial infection and reduce inflammation, leading to fewer exacerbations, fewer symptoms, improved lung function, and improved quality of life. Further evidence is required on the efficacy of macrolides in terms of specific bacterial eradication and the extent of antibiotic resistance. Objectives To determine the impact of macrolide antibiotics in the treatment of adults and children with bronchiectasis. Search methods We identified trials from the Cochrane Airways Trials Register, which contains studies identified through multiple electronic searches and handsearches of other sources. We also searched trial registries and reference lists of primary studies. We conducted all searches on 18 January 2018. Selection criteria We included randomised controlled trials (RCTs) of at least four weeks' duration that compared macrolide antibiotics with placebo or no intervention for the long-term management of stable bronchiectasis in adults or children with a diagnosis of bronchiectasis by bronchography, plain film chest radiograph, or high-resolution computed tomography. We excluded studies in which participants had received continuous or high-dose antibiotics immediately before enrolment or before a diagnosis of cystic fibrosis, sarcoidosis, or allergic bronchopulmonary aspergillosis. Our primary outcomes were exacerbation, hospitalisation, and serious adverse events. Data collection and analysis Two review authors independently screened the titles and abstracts of 103 records. We independently screened the full text of 40 study reports and included 15 trials from 30 reports. Two review authors independently extracted outcome data and assessed risk of bias for each study. We analysed dichotomous data as odds ratios (ORs) and continuous data as mean differences (MDs) or standardised mean differences (SMDs). We used standard methodological procedures as expected by Cochrane. Main results We included 14 parallel-group RCTs and one cross-over RCT with interventions lasting from 8 weeks to 24 months. Of 11 adult studies with 690 participants, six used azithromycin, four roxithromycin, and one erythromycin. Four studies with 190 children used either azithromycin, clarithromycin, erythromycin, or roxithromycin. We included nine adult studies in our comparison between macrolides and placebo and two in our comparison with no intervention. We included one study with children in our comparison between macrolides and placebo and one in our comparison with no intervention. In adults, macrolides reduced exacerbation frequency to a greater extent than placebo (OR 0.34, 95% confidence interval (CI) 0.22 to 0.54; 341 participants; three studies; I2 = 65%; moderate-quality evidence). This translates to a number needed to treat for an additional beneficial outcome of 4 (95% CI 3 to 8). Data show no differences in exacerbation frequency between use of macrolides (OR 0.31, 95% CI 0.08 to 1.15; 43 participants; one study; moderate-quality evidence) and no intervention. Macrolides were also associated with a significantly better quality of life compared with placebo (MD -8.90, 95% CI -13.13 to -4.67; 68 participants; one study; moderate-quality evidence). We found no evidence of a reduction in hospitalisations (OR 0.56, 95% CI 0.19 to 1.62; 151 participants; two studies; I2 = 0%; low-quality evidence), in the number of participants with serious adverse events, including pneumonia, respiratory and non-respiratory infections, haemoptysis, and gastroenteritis (OR 0.49, 95% CI 0.20 to 1.23; 326 participants; three studies; I2 = 0%; low-quality evidence), or in the number experiencing adverse events (OR 0.83, 95% CI 0.51 to 1.35; 435 participants; five studies; I2 = 28%) in adults with macrolides compared with placebo. In children, there were no differences in exacerbation frequency (OR 0.40, 95% CI 0.11 to 1.41; 89 children; one study; low-quality evidence); hospitalisations (OR 0.28, 95% CI 0.07 to 1.11; 89 children; one study; low-quality evidence), serious adverse events, defined within the study as exacerbations of bronchiectasis or investigations related to bronchiectasis (OR 0.43, 95% CI 0.17 to 1.05; 89 children; one study; low-quality evidence), or adverse events (OR 0.78, 95% CI 0.33 to 1.83; 89 children; one study), in those receiving macrolides compared to placebo. The same study reported an increase in macrolide-resistant bacteria (OR 7.13, 95% CI 2.13 to 23.79; 89 children; one study), an increase in resistance to Streptococcus pneumoniae (OR 13.20, 95% CI 1.61 to 108.19; 89 children; one study), and an increase in resistance to Staphylococcus aureus (OR 4.16, 95% CI 1.06 to 16.32; 89 children; one study) with macrolides compared with placebo. Quality of life was not reported in the studies with children. Authors' conclusions Long-term macrolide therapy may reduce the frequency of exacerbations and improve quality of life, although supporting evidence is derived mainly from studies of azithromycin, rather than other macrolides, and predominantly among adults rather than children. However, macrolides should be used with caution, as limited data indicate an associated increase in microbial resistance. Macrolides are associated with increased risk of cardiovascular death and other serious adverse events in other populations, and available data cannot exclude a similar risk among patients with bronchiectasis
Meditation-induced bliss viewed as release from conditioned neural (thought) patterns that block reward signals in the brain pleasure center
The nucleus accumbens orchestrates processes related to reward and pleasure,
including the addictive consequences of repeated reward (e.g., drug addiction and
compulsive gambling) and the accompanying feelings of craving and anhedonia.
The neurotransmitters dopamine and endogenous opiates play interactive roles in
these processes. They are released by natural rewards (i.e., food, water, sex, money,
play, etc.) and are released or mimicked by drugs of abuse. Repeated drug use
induces conditioned down-regulation of these neurotransmitters, thus causing
painful suppression of everyday pleasure. As with many spiritual traditions,
Buddhism provides strong advice against the pursuit of worldly pleasures to
attain the ‘‘good life.’’ In contrast, many forms of meditation give rise to an
immense and abiding joy. Most of these practices involve ‘‘stilling the mind,’’
whereby all content-laden thought (e.g., fantasies, daydreams, plans) ceases, and
the mind enters a state of openness, formlessness, clarity, and bliss. This can be
explained by the Buddhist suggestion that almost all of our everyday thoughts are
a form of addiction. It follows that if we turn off this internal ‘‘gossip of ego,’’ we
will find relief from the biochemical dopamine/opiate down-regulation, which is,
perhaps, the perpetual concomitant of our daily rumination
“The end of The Dreyfus affair”: (Post)Heideggerian meditations on man, machine and meaning
In this paper, the possibility of developing a Heideggerian solution to the Schizophrenia Problem associated with cognitive technologies is investigated. This problem arises as a result of the computer bracketing emotion from cognition during human-computer interaction and results in human psychic self-amputation. It is argued that in order to solve the Schizophrenia Problem, it is necessary to first solve the 'hard problem' of consciousness since emotion is at least partially experiential. Heidegger's thought, particularly as interpreted by Hubert Dreyfus, appears relevant in this regard since it ostensibly provides the basis for solving the 'hard problem' via the construction of artificial systems capable of the emergent generation of conscious experience. However, it will be shown that Heidegger's commitment to a non-experiential conception of nature renders this whole approach problematic, thereby necessitating consideration of alternative, post-Heideggerian approaches to solving the Schizophrenia Problem
High speed synchrotron X-ray imaging studies of the ultrasound shockwave and enhanced flow during metal solidification processes
The highly dynamic behaviour of ultrasonic bubble implosion in liquid metal, the multiphase liquid metal flow containing bubbles and particles, and the interaction between ultrasonic waves and semisolid phases during solidification of metal were studied in situ using the complementary ultrafast and high speed synchrotron X-ray imaging facilities housed respectively at the Advanced Photon Source, Argonne National Laboratory, US, and Diamond Light Source, UK. Real-time ultrafast X-ray imaging of 135,780 frames per second (fps) revealed that ultrasonic bubble implosion in a liquid Bi-8 wt. %Zn alloy can occur in a single wave period (30 kHz), and the effective region affected by the shockwave at implosion was 3.5 times the original bubble diameter. Furthermore, ultrasound bubbles in liquid metal move faster than the primary particles, and the velocity of bubbles is 70 ~ 100% higher than that of the primary particles present in the same locations close to the sonotrode. Ultrasound waves can very effectively create a strong swirling flow in a semisolid melt in less than one second. The energetic flow can detach solid particles from the liquid-solid interface and redistribute them back into the bulk liquid very effectively
The superstring Hagedorn temperature in a pp-wave background
The thermodynamics of type IIB superstring theory in the maximally
supersymmetric plane wave background is studied. We compute the thermodynamic
partition function for non-interacting strings exactly and the result differs
slightly from previous computations. We clarify some of the issues related to
the Hagedorn temperature in the limits of small and large constant RR 5-form.
We study the thermodynamic behavior of strings in the case of geometries in the presence of NS-NS and RR 3-form backgrounds. We
also comment on the relationship of string thermodynamics and the thermodynamic
behavior of the sector of Yang-Mills theory which is the holographic dual of
the string theory.Comment: 22 pages, JHEP style, minor misprints corrected, some comments adde
Global conformal anomaly in N=2 string
We show the existence of a global anomaly in the one-loop graphs of N=2
string theory, defined by sewing tree amplitudes, unless spacetime
supersymmetry is imposed. The anomaly is responsible for the non-vanishing
maximally helicity violating amplitudes. The supersymmetric completion of the
N=2 string spectrum is formulated by extending the previous cohomological
analysis with an external spin factor; the target space-time spin-statistics of
these individual fields in a selfdual background are compatible with previous
cohomological analysis as fields of arbitrary spin may be bosonized into one
another. We further analyze duality relations between the open and closed
string amplitudes and demonstrate this in the supersymmetric extension of the
target space-time theory through the insertion of zero-momentum operators.Comment: 29 pages, LaTeX, one figur
- …